Pulmonary Clearance of Moraxella catarrhalis in an Animal Model

Journal of Infectious Diseases

Volumn 165, Issue 4, 1992, Pages 644-650

  Unhanand, Manaswat ^a   Maciver, Isobel ^a   Ramilo, Octavio ^a   Arencibia Mireles, Orlando ^a   Craig Argyle, J ^a   McCracken, George H ^a   Hansen, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HISTOPATHOLOGY; IMMUNE RESPONSE; LOWER RESPIRATORY TRACT; LUNG CLEARANCE; LUNG LAVAGE; MEMBRANE VESICLE; MORAXELLA; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; OUTER MEMBRANE; PHAGOCYTOSIS; PRIORITY JOURNAL; VIRULENCE; VIRUS ISOLATION;

ANIMAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; NEUTROPHILS; PHAGOCYTOSIS; PHENOTYPE; REGRESSION ANALYSIS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0026752570     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/165.4.644     Document Type: Article

References (40)

1. Catlin BW. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev 1990;3:293-320.
2. Van Hare GF, Shurin PA, Marchant CD, et al. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis 1989;9:16-27.
3. Shurin PA. Marchant CD, Kim CH, et al. Emergence of beta-lacta-rnase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis 1983;2:34-8.
4. Kovatch AL, Wald ER, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr 1983;102:261-4.
5. Marchant CD. Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. Am J Med 1990;88(suppl 5A):15S-9S.
6. Malkamaki M, Honkanen E, Leinonen M, Makela PH. Branhamella catarrhalis as a cause of bacterernic pneumonia. Scand J Infect Dis 1983;15:125-6.
7. Wright PW, Wallace RJ Jr. Shepherd JR. A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. Am J Med 1990;88(suppl 5A):2S-8S.
8. Sarubbi FA, Myers JW, Williams JJ, Shell CG. Respiratory infections caused by Branhamella catarrhalis: selected epidemiologic features. Am J Med 1990;88(suppl 5A):9S-14S.
9. Nicotra B, Rivera M, Luman JI, Wallace RJ Jr. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986; 146:890-3.
10. Slevin NJ, Aitkin J, Thornley PE. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet 1984; 1:782-3.
11. McLeod DT, Ahmad F, Capewell S, Croughan MJ, Calder MA, Seaton A. Increase in bronchopulmonary infection due to Branhamella catarrhalis. Br Med J [C1in Res] 1986;292:1103-5.
12. West M, Berk SL, Smith JK. Branhamella catarrhalis pneumonia. South Med J 1982;75:1021-3.
13. Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infection. Rev Infect Dis 1987;9:1140-9.
14. Louie MH, Gabay EL, Mathisen GE, Finegold SM. Branhamella catarrhalis pneumonia. West J Med 1983;138:47-9.
15. Niname G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: I I cases assessed by transtracheal puncture. BrMed J 1978; 1:276-8.
16. McNeely OJ, Kitchens CS, Kluge RM. Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunocompromised host. Am Rev Respir Dis 1976; 114:399-402.
17. Patterson TF, Patterson JE, Masecar BZ, Barden GE. Heirholzer WJ Jr. Zervos MJ. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988;157:996-1001.
18. Murphy TF, Bartos Le. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun 1989;57:2938-41.
19. Goldblatt D, Turner MW, Levinsky RL. Branhamella catarrhalis: anti-genic determinants and the development of the IgG subclass response in childhood. J Infect Dis 1990; 162:1128-35.
20. Doyle WJ. Animal models of otitis media: other pathogens. Pediatr Infect Dis J 1989;8(suppl):S45-7.
21. Murphy TF, Loeb MR. Isolation of the outer membrane of Branhamella catarrhalis. Microb Pathog 1989;6:159-74.
22. Hansen EJ, Frisch CF, McDade RL Jr. Johnston KH. Identification of immunologic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system. Infect Immun 1981;32:1084-92.
23. Kimura A, Gulig PA, McCracken GH Jr, Loftus TA, Hansen EJ. A minor high molecular weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. Infect Immun 1985;47:253-9.
24. Patrick Cc. Kimura A, Jackson MA, et al. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun 1987;55:2902-11.
25. Kimura A, Hansen EJ. Antigenic and phenotypic variations of Haemophilus injluenzae type b lipooligosaccharide and their relationship to virulence. Infect Immun 1986;51:69-79.
26. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipooligosaccharide in polyacrylamide gels. Anal Biochern 1982; 119:115-9.
27. Toews GB, Viroslav SG, Hart DA, Hansen OJ. Pulmonary clearance of encapsulated and unencapsulated Haemophilus infiuenzae strains. Infect Immun 1984;45:437-42.
28. Toews GB, Vial We. Hansen EJ. Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus inftuenzae from mu-rine lungs. Infect Immun 1985;50:207-12.
29. Hansen EJ, Hart DA, McGehee JL, Toews GB. Immune enhancement of pulmonary clearance of nontypable Haemophilus injluenzae. Infect Immun 1988;56:182-90.
30. Jonckheere AR. A distribution-free k-sarnple test against ordered alternatives. Biometrika 1954;41:133-45.
31. Seber GAF. Linear regression analysis. New York: John Wiley & Sons, 1977.
32. Doern GV, Morse SA. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J C1in Microbiol 1980;11:193-5.
33. Bartos LC, Murphy TF. Comparison of outer membrane proteins of 50 strains of Branhamella catarrhalis. J Infect Dis 1988; 158:761-5.
34. Murphy TF. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J 1989;8(suppl):S75-7.
35. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978;64:564-70.
36. Onofrio JM, Shulkin AN, Heidbrink PJ, Toews GB, Pierce AK. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. Am Rev Respir Dis 1981;123:222-5.
37. Verghese A, Berro E, Berro J, Franzus BW. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection. J Infect Dis 1990; 162:1189-92.
38. McGehee JL, Radolf JD, Toews GB, Hansen EJ. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae. Am J Respir Cell Mol Biol 1989;1:201-10.
39. Lees AW, McNaught W. Bacteriology of lower respiratory tract secretions, sputum, and upper respiratory tract secretions in “normals” and chronic bronchitis. Lancet 1959;2:1112-4.
40. Musher OM, Kubitshek KR, Crennan J, Baughn RE. Pneumonia and acute febrile tracheobronchitis due to Haemophilus injluenzae. Ann Intern Med 1983;99:444-50.